| Literature DB >> 35214618 |
María Julia Ajejas Bazán1,2,3, Ramón Del Gallego-Lastra1,4, Cristina Maria Alves Marques-Vieira5, Candelas López-López1,3,6,7, Silvia Domínguez-Fernández3,8, Milagros Rico-Blázquez1,3,9, Francisco Javier Pérez-Rivas1,3.
Abstract
Vaccination against influenza and SARS-CoV-2 is recommended in health sciences students to reduce the risk of acquiring these diseases and transmitting them to patients. The aim of the study was to evaluate how the pandemic influenced the modification of influenza vaccination coverage during the 2019/2020 and 2021/2022 campaigns and to analyze the vaccination coverage against SARS-CoV-2 in health sciences students. A cross-sectional study was conducted among students of the Faculty of Nursing, Physiotherapy and Podiatry of the Complutense University of Madrid. A questionnaire was administered in two stages, the first, Q1, before the start of the pandemic, where we analyzed influenza coverage during the 2019/2020 campaign and a second, Q2, 18 months after the start of the pandemic where we analyzed influenza coverage during the 2021/2022 campaign and coverage against SARS-CoV-2. A total of 1894 students (58.78% of the total of those enrolled) participated. Flu vaccination coverage increased from 26.7% in Q1 to 35.0% in Q2 (p < 0.05), being higher in the age group older than 21 years, who studied nursing, were in their fourth year and lived with people at risk. Vaccination coverage against SARS-CoV-2 was very high (97.8%), especially in students vaccinated against influenza. Coverage of the influenza vaccine in health sciences students increased from 2019-2020 to 2021-2022, being higher in the age group older than 21 years, who studied nursing, were in their first and fourth year and lived with people at risk. Coverage of the SARS-CoV-2 vaccine in health sciences students was very high, especially in those vaccinated against influenza.Entities:
Keywords: COVID-19 vaccines; health occupation; influenza vaccines; students; vaccination coverage
Year: 2022 PMID: 35214618 PMCID: PMC8875301 DOI: 10.3390/vaccines10020159
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Characteristics of the sample for Q1 and Q2.
| Variables | Total (Q1,Q2) | Q1 | Q2 | |
|---|---|---|---|---|
| Sex | Female | 1532 (80.9) | 743 (48.5) | 789 (51.5) |
| Male | 362 (19.1) | 191 (52.8) | 171 (47.2) | |
| Aggregate age | <21 years old | 1176 (62.1) | 591 (50.3) | 585 (49.7) |
| ≥21 years | 718 (37.9) | 343 (47.8) | 375 (52.2) | |
| Degree | Nursing | 1336 (70.5) | 624 (46.7) | 712 (53.3) |
| Physiotherapy | 266 (14.0) | 162(60.9) | 104 (39.1) | |
| Podiatry | 292 (15.4) | 148(50.7) | 144 (49.3) | |
| Grade | 1 | 547 (28.9) | 292 (53.4) | 255 (46.6) |
| 2 | 509 (26.9) | 300 (58.9) | 209 (41.1) | |
| 3 | 431 (22.8) | 178 (41.3) | 253 (58.7) | |
| 4 | 407 (21.5) | 164 (40.3) | 243 (59.7) | |
Flu vaccination coverage by sex, age, degree and course in Q1 and Q2.
| Variables | Categories | Q1 | Q2 | |
|---|---|---|---|---|
| Sex | Female | 202 (27.2) | 277 (35.1) | |
| Male | 48 (25.1) | 59 (34.7) | 0.031 | |
| Age | <21 years | 155 (26.2) | 175 (30.0) | 0.087 |
| ≥21 years | 95 (27.7) | 161 (42.9) | ||
| Degree | Nursing | 203 (32.5) | 278 (39.0) | 0.008 |
| Physiotherapy | 29 (17.9) | 26 (25.0) | 0.108 | |
| Chiropody | 18 (12.2) | 32 (22.4) | 0.015 | |
| Course year for all degrees taken together | 1st | 38 (13.0) | 62 (24.3) | |
| 2nd | 121 (40.3) | 84 (40.2) | 0.524 | |
| 3rd | 56 (31.5) | 72 (28.6) | 0.295 | |
| 4th | 35 (21.3) | 118(48.6) |
Influenza vaccine coverage according to factors related to COVID infection (in students participating in Q2).
| Variables | Q2 | ||
|---|---|---|---|
| n (%) | |||
| Country of birth | Spain | 305 (35.2) | 0.717 |
| Other | 31 (33.3) | ||
| Has been vaccinated against SARS-CoV-2 | Yes | 333 (35.5) | 0.044 |
| No | 3 (14.3) | ||
| Has been diagnosed with COVID-19? | Yes | 81 (35.5) | 0.859 |
| No | 255 (34.9) | ||
| Type of symptomatology after being diagnosed with COVID | I have not passed COVID infection 19 | 248 (34.7) | 0.813 |
| Asymptomatic | 22 (32.8) | ||
| Mild case | 63 (36.6) | ||
| Severe | 3 (50.0) | ||
| Has anyone you know close to you been COVID-19 | Yes | 152 (34.9) | 0.956 |
| No | 184 (35.1) | ||
| Do you live with people at risk? | Yes | 159 (42.1) | |
| No | 177 (30.5) | ||
Multivariate model using logistic regression: variables influencing influenza vaccination coverage.
| Dependent Variable | Independent Variables | Coefficients | OR (95%CI) | |
|---|---|---|---|---|
| Vaccination to influenza | Course Year 4th | 0.929 | 2.53 (1.83–3.50) | |
| Nursing | 0.682 | 1.98 (1.41–2.77) | ||
| Course Year 2rd | 0.663 | 1.94 (1.37–2.74) | ||
| Cohabitation with at-risk patient | 0.514 | 1.67 (1.27–2.21) | ||
| Constant | −1756 | 0.063 | 0.007 |
Characteristics of the Q2 student population in relation to COVID infection 19.
| Variables | Q2 | |
|---|---|---|
| Has been vaccinated against SARS-CoV-2 | Yes | 939 (97.8) |
| No | 21 (2.2) | |
| Has been diagnosed with COVID-19? | Yes | 245 (25.6) |
| No | 715 (74.4) | |
| Type of symptomatology after being diagnosed with COVID | Asymptomatic | 67 (27.3) |
| Mild case | 172 (70.2) | |
| Severe | 6 (2.5) | |
| Has anyone close to you been a COVID-19 case? | Yes | 436 (45.4) |
| No | 524 (54.6) | |
| Do you live with people at risk? | Yes | 379 (39.5) |
| No | 581 (60.5) | |
Severity of COVID-19 as a function of different factors.
| Variables | Asymptomatic | Mild Clinical | Sever Clinical | ||
|---|---|---|---|---|---|
| Sex | Female | 46 (68.7) | 148 (86.0) | 5 (83.3) | 0.144 |
| Male | 21 (31.3) | 24 (14.0) | 1 (16.7) | ||
| Age | <21 years old | 42 (62.7) | 111 (64.5) | 1 (16.7) | 0.017 |
| ≥21 years old | 25 (37.3) | 61 (35.5) | 5 (83.3) | ||
| Country of birth | Spain | 57 (85.1) | 149 (86.6) | 6 (100.0) | 0.079 |
| Others | 10 (14.9) | 23 (13.4) | 0 (0.0) | ||
| Grade | Nursing | 42 (62.7) | 136 (79.1) | 5 (83.3) | 0.016 |
| Physiotherapy | 16 (23.9) | 16 (9.3) | 0 (0.0) | ||
| Podiatry | 9 (13.4) | 20 (11.6) | 1 (16.7) | ||
| Course | 1 | 17 (25.4) | 57 (33.1) | 3 (50.0) | 0.069 |
| 2 | 11 (16.4) | 26 (15.1) | 0 (0.0) | ||
| 3 | 23 (34.3) | 50 (29.1) | 2 (33.3) | ||
| 4 | 16 (23.9) | 39 (22.7) | 1 (16.7) | ||
| Influenza vaccinated Q2 | Yes | 22 (32.8) | 63 (36.6) | 3 (50.0) | 0.813 |
| No | 45 (67.2) | 109 (63.4) | 3 (50.0) | ||
| COVID-19 vaccinated | Yes | 63 (94.0) | 162 (94.2) | 6 (100.0) | |
| No | 4 (6.0) | 10 (5.8) | 0 (0.0) | ||
Multivariate model using logistic regression: variables influencing vaccination coverage against SARS-CoV-2.
| Dependent Variable | Independent Variables | Coefficients | OR (95%CI) | |
|---|---|---|---|---|
| Vaccination to SARS-CoV-2 | Have passed the COVID infection | −1.329 | 0.27 (0.12–0.65) | 0.003 |
| Have been vaccinated against influenza | 1.21 | 3.36 (0.98–11.54) | 0.054 | |
| Constant | 3.994 | 54.28 |